[A possible adverse effect from the association of losartan-mefenamic acid in hemodialysis]

Nephrologie. 2001;22(2):73.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antihypertensive Agents / adverse effects*
  • Antihypertensive Agents / therapeutic use
  • Atenolol / therapeutic use
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Furosemide / therapeutic use
  • Glomerulonephritis, IGA / complications
  • Glomerulonephritis, IGA / therapy
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Losartan / adverse effects*
  • Losartan / therapeutic use
  • Mefenamic Acid / adverse effects*
  • Mefenamic Acid / therapeutic use
  • Renal Dialysis*

Substances

  • Antihypertensive Agents
  • Cyclooxygenase Inhibitors
  • Mefenamic Acid
  • Atenolol
  • Furosemide
  • Losartan